{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T08:30:05Z","timestamp":1721809805878},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,30]]},"DOI":"10.7759\/cureus.11269","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T03:14:56Z","timestamp":1604114096000},"source":"Crossref","is-referenced-by-count":1,"title":["The Role of Hepatocellular Carcinoma Surveillance in Autoimmune Hepatitis"],"prefix":"10.7759","author":[{"given":"Ahila","family":"Manivannan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Mazumder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"Al-Kourainy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13203","article-title":"Pathogens and autoimmune hepatitis","volume":"195","author":"Christen U","year":"2019","unstructured":"Christen U, Hintermann E. Pathogens and autoimmune hepatitis. Clin Exp Immunol. 2019, 195:35-51. 10.1111\/cei.13203","journal-title":"Clin Exp Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520802130183","article-title":"Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study","volume":"43","author":"Werner M","year":"2008","unstructured":"Werner M, Prytz H, Ohlsson B, et al.. Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand J Gastroenterol. 2008, 43:1232-1240. 10.1080\/00365520802130183","journal-title":"Scand J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-015-0386-y","article-title":"Autoimmune hepatitis","volume":"9","author":"Sahebjam F","year":"2015","unstructured":"Sahebjam F, Vierling JM. Autoimmune hepatitis. Front Med. 2015, 9:187-219. 10.1007\/s11684-015-0386-y","journal-title":"Front Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)62163-1","article-title":"Autoimmune hepatitis","volume":"382","author":"Heneghan MA","year":"2013","unstructured":"Heneghan MA, Yeoman AD, Verma S, Smith AD, Longhi MS. Autoimmune hepatitis. Lancet. 2013, 382:1433-1444. 10.1016\/S0140-6736(12)62163-1","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes EM","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, et al.. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008, 48:169-176. 10.1002\/hep.22322","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","volume":"72","author":"Mack CL","year":"2020","unstructured":"Mack CL, Adams D, Assis DN, et al.. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases. Hepatology. 2020, 72:671-722. 10.1002\/hep.31065","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.02.006","article-title":"Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis","volume":"15","author":"Tansel A","year":"2017","unstructured":"Tansel A, Katz LH, El-Serag HB, et al.. Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017, 15:1207-1217. 10.1016\/j.cgh.2017.02.006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.08.014","article-title":"Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice","volume":"13","author":"Singal AG","year":"2015","unstructured":"Singal AG, El-Serag HB. Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice. Clin Gastroenterol Hepatol. 2015, 13:2140-2151. 10.1016\/j.cgh.2015.08.014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref9","unstructured":"Cancer facts and figures 2020. (2020). Accessed. August 29, 2020: https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/cancer-facts-figures-2020.html."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i13.1550","article-title":"Hepatocellular carcinoma surveillance: an evidence-based approach","volume":"25","author":"Harris PS","year":"2019","unstructured":"Harris PS, Hansen RM, Gray ME, Massoud OI, McGuire BM, Shoreibah MG. Hepatocellular carcinoma surveillance: an evidence-based approach. World J Gastroenterol. 2019, 25:1550-1559. 10.3748\/wjg.v25.i13.1550","journal-title":"World J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228857","article-title":"The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"15","author":"Zhang J","year":"2020","unstructured":"Zhang J, Chen G, Zhang P, et al.. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Plos One. 2020, 15:e0228857. 10.1371\/journal.pone.0228857","journal-title":"Plos One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14081","article-title":"Racial disparities in presentation and outcomes of paediatric autoimmune hepatitis","volume":"39","author":"Palle SK","year":"2019","unstructured":"Palle SK, Naik KB, Mccracken CE, Kolachala VL, Romero R, Gupta NA. Racial disparities in presentation and outcomes of paediatric autoimmune hepatitis. Liver International. 2019, 39:976-984. 10.1111\/liv.14081","journal-title":"Liver International"},{"key":"ref13","article-title":"Treatment of hepatocellular carcinoma with lenvatinib","volume":"14","author":"Han KH","year":"2018","unstructured":"Han KH. Treatment of hepatocellular carcinoma with lenvatinib. Gastroenterol Hepatol N Y. 2018, 14:662-664.","journal-title":"Gastroenterol Hepatol N Y"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22432","article-title":"Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening","volume":"48","author":"Yeoman AD","year":"2008","unstructured":"Yeoman AD, Al-Chalabi T, Karani JB, et al.. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening. Hepatology. 2008, 48:863-870. 10.1002\/hep.22432","journal-title":"Hepatology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/41576-the-role-of-hepatocellular-carcinoma-surveillance-in-autoimmune-hepatitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:19:04Z","timestamp":1707506344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/41576-the-role-of-hepatocellular-carcinoma-surveillance-in-autoimmune-hepatitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.11269","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,30]]}}}